Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$50,000.00
Jan 21, 2021
For-profit organization
Strengthening Biosecurity in Africa, the BTWCand the G7-led Global Partnership
7427575 P010069001
This Project will support the organisation and implementation of three virtual conferences, which aim to advance DFATD priorities within the Global Partnership Against the Spread of Weapons and Materials of Mass Destruction.
$25,643.00
Jan 21, 2021
Not-for-profit organization or charity
Contribution to Black Empowered Woman
16827
Raising awareness on gender-based violence through an advocacy campaign including panel discussions
$303,341.00
Jan 21, 2021
Academia
Newcastle Disease Virus (NDV) as a novel platform for development of COVID-19 vaccines
964417
The University of Guelph developed a vaccine to protect against the novel coronavirus disease that emerged in 2019 (COVID-19) using a safe vector known as avian orthoavulavirus-1 (AOaV-1) with a transgene encoding the full-length spike protein (FLS) from severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). In a hamster challenge model of COVID-19, intranasal vaccination with AOaV-1-FLS completely protected against disease, and SARS-CoV-2 could not be detected. This correlated with the induction of a SARS-CoV-2-specific immune responses in the lungs. The next step requires that this vaccine be optimized for administration into the respiratory system of humans. Specifically, the vaccine vector needs to be adapted to function across a broad range of temperatures, including the relatively low temperature of the nasal passages and the higher temperatures in the lungs. Also, intranasal versus aerosol delivery into the respiratory system will be tested to determine if nasal and/or respiratory delivery induces protective immune responses. In parallel, a next-generation version of the vaccine that expresses a prefusion stabilized SARS-CoV-2 spike protein will be engineered and tested in mice and hamster COVID-19 challenge models. This research will pave the way toward a human clinical trial.
$303,341.00
Jan 21, 2021
Academia
Newcastle Disease Virus (NDV) as a novel platform for development of COVID-19 vaccines
964417
The University of Guelph developed a vaccine to protect against the novel coronavirus disease that emerged in 2019 (COVID-19) using a safe vector known as avian orthoavulavirus-1 (AOaV-1) with a transgene encoding the full-length spike protein (FLS) from severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). In a hamster challenge model of COVID-19, intranasal vaccination with AOaV-1-FLS completely protected against disease, and SARS-CoV-2 could not be detected. This correlated with the induction of a SARS-CoV-2-specific immune responses in the lungs. The next step requires that this vaccine be optimized for administration into the respiratory system of humans. Specifically, the vaccine vector needs to be adapted to function across a broad range of temperatures, including the relatively low temperature of the nasal passages and the higher temperatures in the lungs. Also, intranasal versus aerosol delivery into the respiratory system will be tested to determine if nasal and/or respiratory delivery induces protective immune responses. In parallel, a next-generation version of the vaccine that expresses a prefusion stabilized SARS-CoV-2 spike protein will be engineered and tested in mice and hamster COVID-19 challenge models. This research will pave the way toward a human clinical trial.
$279,408.00
Jan 21, 2021
For-profit organization
Sensor integration on a Canadian coast guard vessel to assist in characterization of the ice environment
964449
The collaborative research Project develops a scientific research methodology to deploy sensors aboard an ice-going ship (Canadian Coast Guard Icebreaker CCGS Henry Larsen) in order to measure ice severity.
$1,500.00
Jan 21, 2021
For-profit organization
Assessment Project - Ancor Transport Ltd.
GC-129828S
This project increases knowledge and capacity for the on-road freight sector to improve efficiency.
$49,999.00
Jan 21, 2021
Aboriginal recipient
BUILDING COMMUNITY CAPACITY IN EMERGENCY PREPAREDNESS & RESPONSE - PLANNING ACTIVITIES
GC-129912S
The objective of this Project is to advance Indigenous issues and priorities in environment, safety and/or socioeconomic imperatives, consistent with the Terms of Reference of the Indigenous Advisory and Monitoring Committee for the Trans Mountain Expansion Project.
$49,999.00
Jan 21, 2021
Aboriginal recipient
BUILDING COMMUNITY CAPACITY IN EMERGENCY PREPAREDNESS & RESPONSE - PLANNING ACTIVITIES
GC-129912S
The objective of this Project is to advance Indigenous issues and priorities in environment, safety and/or socioeconomic imperatives, consistent with the Terms of Reference of the Indigenous Advisory and Monitoring Committee for the Trans Mountain Expansion Project.
$100,000.00
Jan 21, 2021
Other
Atlantic Canada’s Net-Zero Future: A Feasibility Study of Hydrogen in Atlantic Canada
GC-129861S
This project supports activities that advance low-carbon fuels in Canada.
$50,000.00
Jan 21, 2021
Academia
Identification and Assessment of Opportunities for Hydrogen in Alberta's Economy
GC-129866S
This project supports activities that advance low-carbon fuels in Canada.